Vetoquinol SA (EPA: VETO)
France
· Delayed Price · Currency is EUR 74.30
-2.70 (-3.51%)
Dec 20, 2024, 5:35 PM CET
Vetoquinol Revenue
Vetoquinol had revenue of 264.44M EUR in the half year ending June 30, 2024, a decrease of -2.34%. This brings the company's revenue in the last twelve months to 537.47M, up 2.32% year-over-year. In the year 2023, Vetoquinol had annual revenue of 529.27M, down -1.95%.
Revenue (ttm)
537.47M
Revenue Growth
+2.32%
P/S Ratio
1.64
Revenue / Employee
213.37K
Employees
2,440
Market Cap
879.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 529.27M | -10.51M | -1.95% |
| Dec 31, 2022 | 539.78M | 18.51M | 3.55% |
| Dec 31, 2021 | 521.27M | 93.81M | 21.94% |
| Dec 31, 2020 | 427.47M | 31.48M | 7.95% |
| Dec 31, 2019 | 395.99M | 28.05M | 7.62% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech S.A. | 2.74B |
| bioMérieux S.A. | 3.81B |
| Eurofins Scientific SE | 6.72B |
| Ipsen S.A. | 3.44B |
| Virbac SA | 1.34B |
| Ramsay Générale de Santé SA | 5.01B |